Closing Bell Overtime: Stocks Keep Rallying, Biotech Buyout Boom & Under the Radar Housing Play 12/26/23

Stocks surging again as the major averages try to extend an 8-week win streak. Long-time bull Tom Lee says the market can keep rallying in the new year – and reveals which group he thinks can soar 50%. Another day, another buyout in the biotech industry. This time it's two deals. Astrazeneca acquiring Gracell Biotechnoligies for $1.2B and Bristol Myers buying Rayzebio for $4.1b and comes just days after Bristol announced a $14b deal for Karuna Therapeutics. Wedbush Biotech analyst Laura Chico says the M&A action should continue next year and names her top picks in the space. The Mastercard spending pulse report shows holiday retail sales increased 3% from a year ago despite retailers warning about spending concerns. Neuberger Berman's John San Marco and Bernstein's Nikhil Devnani name their top retail and e-commerce picks. And Frontdoor CEO Bill Cobb discusses his red hot stock, which has been soaring along with the housing market. He discusses whether consumers are still spending on home warranties and repairs and if he is able to increase prices.